182 related articles for article (PubMed ID: 3118085)
1. Effects of aldose reductase inhibitor (M79175) on ERG oscillatory potential abnormalities in streptozotocin fructose-induced diabetes in rats.
Funada M; Okamoto I; Fujinaga Y; Yamana T
Jpn J Ophthalmol; 1987; 31(2):305-14. PubMed ID: 3118085
[TBL] [Abstract][Full Text] [Related]
2. [Effect of aldose reductase inhibitor (M79175) on the oscillatory potential in ERG of streptozotocin-fructose induced diabetic rats].
Funada M; Okamoto I; Fujinaga Y; Yamana T
Nippon Ganka Gakkai Zasshi; 1985 Oct; 89(10):1111-9. PubMed ID: 3938182
[No Abstract] [Full Text] [Related]
3. Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myo-inositol supplementation and aldose reductase inhibition.
Goldfarb S; Simmons DA; Kern EF
Trans Assoc Am Physicians; 1986; 99():67-72. PubMed ID: 3111062
[No Abstract] [Full Text] [Related]
4. Administration of an aldose reductase inhibitor induces a decrease of collagen fluorescence in diabetic rats.
Suárez G; Rajaram R; Bhuyan KC; Oronsky AL; Goidl JA
J Clin Invest; 1988 Aug; 82(2):624-7. PubMed ID: 3136193
[TBL] [Abstract][Full Text] [Related]
5. Effect of an aldose reductase inhibitor, SNK-860, on deficits in the electroretinogram of diabetic rats.
Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Naruse K; Sasaki H; Mizuno K; Matsubara A; Kakuta H
Exp Physiol; 1995 Nov; 80(6):981-9. PubMed ID: 8962712
[TBL] [Abstract][Full Text] [Related]
6. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
Ono H; Nozawa Y; Hayano S
Nippon Ganka Gakkai Zasshi; 1982; 86(9):1343-50. PubMed ID: 6818854
[No Abstract] [Full Text] [Related]
7. Effects of aldose reductase inhibition on the retina and health indices of streptozotocin-diabetic rats.
Kozak WM; Marker NA; Elmer KK
Doc Ophthalmol; 1986; 64(4):355-77. PubMed ID: 2958262
[TBL] [Abstract][Full Text] [Related]
8. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M
Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340
[TBL] [Abstract][Full Text] [Related]
9. [Diabetic changes in pupillary reaction and iridal pathology. No. 1. The role of aldose reductase to the delayed pupillary reaction in galactose-fed rats].
Terubayashi H; Akagi Y; Kador PF; Kinoshita JH
Nippon Ganka Gakkai Zasshi; 1988 Mar; 92(3):484-8. PubMed ID: 3137794
[No Abstract] [Full Text] [Related]
10. Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats.
Kojima K; Matsubara H; Harada T; Mizuno K; Suzuki M; Hotta N; Kakuta H; Sakamoto N
Jpn J Ophthalmol; 1985; 29(1):99-109. PubMed ID: 3159927
[TBL] [Abstract][Full Text] [Related]
11. [Diabetic changes in pupillary reactions and iris histology. No. 3. The role of aldose reductase inhibitor to iridal vessel hyperpermeability of galactose-fed rats].
Kador PF; Kinoshita JH; Terubayashi H; Akagi Y; Kador PF; Kinoshita JH
Nippon Ganka Gakkai Zasshi; 1988 Oct; 92(10):1577-81. PubMed ID: 3145680
[No Abstract] [Full Text] [Related]
12. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
Datiles M; Fukui H; Kuwabara T; Kinoshita JH
Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419
[TBL] [Abstract][Full Text] [Related]
13. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
Nozawa H; Yaginuma T; Mizuno A
Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):194-201. PubMed ID: 3133929
[No Abstract] [Full Text] [Related]
14. Altering the course of cataracts in diabetic rats.
Fukushi S; Merola LO; Kinoshita JH
Invest Ophthalmol Vis Sci; 1980 Mar; 19(3):313-5. PubMed ID: 6766909
[TBL] [Abstract][Full Text] [Related]
15. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
Hotta N; Sakamoto N
Nihon Rinsho; 1987 Dec; 45(12):3010-27. PubMed ID: 3128677
[No Abstract] [Full Text] [Related]
16. [Prevention of experimental diabetic corneal endotheliopathy with aldose reductase inhibitor].
Akagi Y; Takahashi Y; Tanabe T; Ikebe H; Majima K; Miyatani H; Miyamoto Y; Terubayashi H
Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):187-93. PubMed ID: 3111199
[No Abstract] [Full Text] [Related]
17. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175.
Sato S; Mori K; Wyman M; Kador PF
Exp Eye Res; 1998 Feb; 66(2):217-22. PubMed ID: 9533847
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of orally administered activated charcoal on intestinal dialysis of intravenously administered M79175, an aldose reductase inhibitor, in rats.
Arimori K; Mishima M; Iwaoku R; Nakano M
J Pharmacobiodyn; 1987 Jun; 10(6):243-9. PubMed ID: 3118006
[TBL] [Abstract][Full Text] [Related]
19. [A study of the limitations of ARI treatment of streptozotocin-induced diabetic cataracts].
Kojima M; Sasaki K
Nippon Ganka Gakkai Zasshi; 1986 Dec; 90(12):1669-73. PubMed ID: 2950739
[No Abstract] [Full Text] [Related]
20. [The intraocular penetration of aldose reductase inhibitor in rat eyes].
Kojima M; Sasaki K
Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):57-62. PubMed ID: 3133930
[No Abstract] [Full Text] [Related]
[Next] [New Search]